Depot-related and thiazolidinedione-responsive expression of uncoupling protein 2 (UCP2) in human adipocytes

International Journal of Obesity

Volumn 24, Issue 5, 2000, Pages 585-592

  Digby, J E ^a   Crowley, V E F ^a   Sewter, C P ^a   Whitehead, J P ^a   Prins, J B ^a   O'Rahilly, S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Confocal immunofluorescence microscopy; Human adipose tissue; Mitochondria; RT PCR; Thiazolidinedione; Uncoupling protein 2

Indexed keywords

MESSENGER RNA; ROSIGLITAZONE; THIAZOLIDINE DERIVATIVE; UNCOUPLING PROTEIN 2;

ADIPOCYTE; ADULT; AGED; ANIMAL CELL; ARTICLE; BODY MASS; CELL DIFFERENTIATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CHO CELL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MAMMAL CELL; MITOCHONDRION; NONHUMAN; OMENTUM; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT;

EID: 0034030282     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801201     Document Type: Article

References (37)

1. 1 Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levimeyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, Warden CH. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinaemia. Nature Genet 1997; 15: 269-272.
2. 2 Gimeno RE, Dembski M, Weng X, Deng N, Shyjan A, Gimeno CJ, Iris F, Ellis SJ, Woolf EA, Tartaglia LA. Cloning and characterisation of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes 1997; 46: 900-906.
3. 3 Boss O, Samec S, Paolini-Giacobino A, Rosier C, Dulloo A, Seydoux J, Muzzin P, Giacobino JP. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue specific expression. FEBS Lett 1997; 408: 39-42.
4. 4 Bouchard C, Pérusse L, Chagnon YC, Warden C, Riquier D. Linkage between markers in the vicinity of the uncoupling protein-2 gene and resting metabolic rate in humans. Hum Mol Genet 1997; 6: 1887-1889.
5. 5 Walder K, Norman RA, Hanson RL, Schrauwen P, Neverova M, Jenkinson CP, Easlick J et al. Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima Indians. Hum Mol Genet 1998; 7: 1431-1435.
6. 6 Gong DW, He Y, Karas M, Reitman M. Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta 3-adrenergic agonists, and leptin. J Biol Chem 1997; 272: 24129-24132.
7. 7 Millet L, Vidal H, Andreeli F, Larrouy D, Riou JP, Ricquier D, Laville M, Langin D. Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J Clin Invest 1997; 100: 2665-2670.
8. 8 Matsuda Hosoda J, Itoh K, Son H, Doi C, Tanaka K, Fukunaga T, Inoue Y, Nishimura G, Yoshimasa H, Yamori Y, Nakao YK. Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: their gene expression in rats fed high-fat diet. FEBS Lett. 1997; 418: 200-204.
9. 9 Surwit RS, Wang S, Petro AE, Sanchis D, Raimbault S, Ricquier D, Collins S. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strain of mice. Proc Nat Acad Sci USA 1998; 95: 4061-4065.
10. 10 Rebuffé-Scrive M, Andersson B, Olbe L, Bjorntorp P. Metabolism of adipose tissue in intra-abdominal depots of nonobese men and women. Metabolism 1989; 38: 453-458.
11. 11 Martin ML, Jensen MD. Effects of body distribution on regional lipolysis in obesity. J Clin Invest 1991; 88: 609-613.
12. 12 Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 1995; 27: 435-438.
13. 13 Oberkofler H, Liu YM, Esterbauer H, Hell E, Krempler F, Patsch W. Uncoupling protein-2 gene: reduced mRNA expression in intraperitoneal adipose tissue of obese humans. Diabetologia 1998; 41: 940-946.
14. 14 Day C. Thiazolidinediones: a new class of antidiabetic drugs. Diabetic Med 1999; 16: 179-192.
15. 15 Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor-γ (PPARγ). J Biol Chem 1995; 270: 12953-12956.
16. 16 Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chaterjee KK, O'Rahilly S. Activators of peroxisome proliferator-activated receptor-g have depot-specific effects on human preadipocyte differentiation. J Clin Invest 1997; 100: 3149-3153.
17. 17 Spiegelman BM. PPAR-γ adipogenic regulator and thiazolidinedione receptor. Diabetes 1998; 47: 507-514.
18. 18 Rothwell NJ, Stock MJ, Tedstone AE. Effects of ciglitazone on energy balance, thermogenesis and brown fat activity in the rat. Mol Cell Endocrinol 1987; 57: 253-257.
19. 19 Digby JE, Montague CT, Sewter CP, Sanders L, Wilkison WO, O'Rahilly S, Prins J. Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes. Diabetes 1998; 47: 138-141.
20. 20 Camirand A, Marie V, Rabelo R, Silva JE. Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissue and skeletal muscle. Endocrinology 1998; 139: 428-431.
21. 21 Matsuda J, Hosada K, Itoh H, Son C, Doi K, Hanaoka I, Inoue G, Nishimura H, Yoshimasa Y, Yamori Y, Odaka H and Nakao K. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar Fatty rats and in cultured adipocytes. Diabetes 1998; 47: 1809-1814.
22. 22 M. Rodbell. Metabolism of isolated fat cells. J Biol Chem 1964; 239: 375-380.
23. 23 Hauner H, Entenmann G, Wabitsch M, Gaillard D, Ailhaud G, Negrel R, Pfeiffer EF. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells in a chemically defined medium. J Clin Invest 1989; 84: 1663-1670.
24. 24 Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression. Diabetes 1997 46: 342-347.
25. 25 Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, Digby J, Byrne CD, O'Rahilly S. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998; 47: 1384-1391.
26. 26 Sewter CP, Digby JE, Blows F, Prins J, O'Rahilly S. Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. J Endocrinol 1999 163: 33-38.
27. 27 Dib K, Whitehead JP, Humphreys PJ, Soos MA, Baynes KRC, Kumar S, Harvey T, O'Rahilly S. Impaired activation of phosphinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudo-acromegaly: a disorder characterised by selective post-receptor insulin resistance. J Clin Invest 1998; 101: 1111-1120.
28. 28 Qian H, Hausman GJ, Compton MM, Azain MJ, Hartzell DL, Baile CA. Leptin regulation of peroxisome proliferator-activated receptor-γ, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissue. Biochem Biophys Res Commun 1998; 246: 660-667.
29. 29 Kissebah AH, Vydelingum N, Murray M, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocinol Metab 1982; 54: 254-260.
30. 30 Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest 1983; 72: 1150-1162.
31. 31 Ross R, Fortier L, Hudson R. Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women. Diabetes Care 1996; 19: 1404-1411.
32. 32 Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women-direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996; 45: 633-638.
33. 33 Fried SK, Russell CD, Grauso NL, Brolin RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 1993; 92: 2191-2198.
34. 34 Samec S, Seydoux J, Dulloo AG. Interorgan signalling between adipose tissue and skeletal muscle uncoupling protein homologs. Is there a role for circulating free fatty acids? Diabetes 1998; 47: 1693-1698.
35. 35 Wahrenberg H, Lonnqvist F, Armer P. Mechanisms underlying regional differences in lipolysis in human adipose tissue. J Clin Invest 1989; 84: 458-467.
36. 36 Richelsen B, Pedersen SB, Moller-Pedersen T, Bak JF. Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin and prostaglandin e2. Metabolism 1991; 40: 990-996.
37. 37 Bolinder J, Kager L, Östmann J, Arner P. Differences at the receptor and post receptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 1983; 32: 117-123.